Medical Technologies Firm to Create 100+ Jobs at New Wisconsin Facility
SHINE serves the medical tracer industry sector by providing medical ingredients used to detect/treat heart disease and cancer in nearly 100,000 patients each day.
"As a company that grew in partnership with research conducted at UW-Madison and the Morgridge Institute for Research, one of our primary goals was to grow this business in Wisconsin and leverage its talented workforce," said SHINE's Founder/CEO Greg Piefer, Ph.D.
The company's proposed facility, to be located in the STH 11 Business Park, will have the capacity to produce enough moly-99 to supply about half of the U.S. nuclear medical isotope needs. (Moly-99 is a medical isotope to help detect heart disease and determe stages of cancer progression.) Historically, the majority of the moly-99 used in the U.S. has been produced in Canada or from other locations across the globe.
Pending formal approval, SHINE's project will be supported by a combination of resources, including a Janesville Tax Increment Financing (TIF) package and assistance from the Wisconsin Economic Development Corporation. The facility marks the second medical technologies announcement in Rock County within the last eight months.
Dollar General Plans Walton, Kentucky Distribution Center and Bowling Green Cold Storage Hub
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
A Heightened Focus on Reshoring
34th Annual Corporate Survey & the 16th Annual Consultants Survey
How are Uncertain Times Altering Company Location Strategies?